Medical devices, healthcare technology and the business of care
DEVICE CATEGORY · ONU

Drug-Eluting Peripheral Transluminal Angioplasty Catheter

A drug-eluting peripheral transluminal angioplasty catheter is a combination product intended for balloon dilatation of peripheral vasculature to establish or maintain patency. A drug-eluting PTA catheter delivers a drug to the vessel as part of the angioplasty procedure and is intended to inhibit restenosis. Intended to provide percutaneous transluminal angioplasty of lesions in peripheral arteries including iliac, popliteal, femoral, and iliofemoral.

Product / regulatory recordCompanyPathwayDecision dateSource
Medtronic, Inc.PMA supplementSep 24, 2026FDA
BOSTON SCIENTIFIC CORPORATIONPMA supplementAug 4, 2026FDA
LutonixPMA supplementJul 9, 2026FDA
Medtronic, Inc.PMA supplementMay 28, 2026FDA
Medtronic, Inc.PMA supplementMay 21, 2026FDA
Medtronic, Inc.PMA supplementMay 1, 2026FDA
BOSTON SCIENTIFIC CORPORATIONPMA supplementMay 1, 2026FDA
BOSTON SCIENTIFIC CORPORATIONPMA supplementApr 24, 2026FDA
Medtronic, Inc.PMA supplementApr 23, 2026FDA
The Spectranetics Corp.PMA supplementMar 19, 2026FDA
BOSTON SCIENTIFIC CORPORATIONPMA supplementMar 12, 2026FDA
Medtronic, Inc.PMA supplementMar 6, 2026FDA
Medtronic, Inc.PMA supplementFeb 13, 2026FDA
Medtronic, Inc.PMA supplementJan 30, 2026FDA
The Spectranetics Corp.PMA supplementNov 24, 2025FDA
BOSTON SCIENTIFIC CORPORATIONPMA supplementOct 24, 2025FDA
Medtronic, Inc.PMA supplementSep 16, 2025FDA
LutonixPMA supplementSep 4, 2025FDA
Medtronic, Inc.PMA supplementAug 12, 2025FDA
Medtronic, Inc.PMA supplementAug 12, 2025FDA
Medtronic, Inc.PMA approvalDec 30, 2014FDA
Source information

Follow the FDA links to view the original records.

All device categories